Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|January 12, 2011
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2007
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheterGiuseppe Curigliano, Alessandra Balduzzi, Anna Cardillo, et al.
Clinical Breast Cancer|March 1, 2018
Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast CancerAntonella Palazzo, Silvia Dellapasqua, Elisabetta Munzone, et al.
Breast (Edinburgh, Scotland)|July 20, 2010
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancerRosalba Torrisi, Emilia Montagna, Eloise Scarano, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VIIPer Karlsson, Bernard F Cole, Karen N Price, et al.
Anti-Cancer Drugs|August 31, 2006
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancerLaura Orlando, Anna Cardillo, Andrea Rocca, et al.
Breast Cancer Research and Treatment|October 5, 2021
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysisNadia Bianco, Monica Milano, Eleonora Pagan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
Journal of the National Cancer Institute|December 18, 2003
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial, Monica Castiglione-Gertsch, Anne O'Neill, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|January 12, 2011
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2007
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheterGiuseppe Curigliano, Alessandra Balduzzi, Anna Cardillo, et al.
Clinical Breast Cancer|March 1, 2018
Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast CancerAntonella Palazzo, Silvia Dellapasqua, Elisabetta Munzone, et al.
Breast (Edinburgh, Scotland)|July 20, 2010
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancerRosalba Torrisi, Emilia Montagna, Eloise Scarano, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VIIPer Karlsson, Bernard F Cole, Karen N Price, et al.
Anti-Cancer Drugs|August 31, 2006
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancerLaura Orlando, Anna Cardillo, Andrea Rocca, et al.
Breast Cancer Research and Treatment|October 5, 2021
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysisNadia Bianco, Monica Milano, Eleonora Pagan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
Journal of the National Cancer Institute|December 18, 2003
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial, Monica Castiglione-Gertsch, Anne O'Neill, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Pageof 27